These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29609689)

  • 1. Regorafenib delays the proliferation of hepatocellular carcinoma by inducing autophagy.
    Han R; Li S
    Pharmazie; 2018 Apr; 73(4):218-222. PubMed ID: 29609689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor.
    D'Alessandro R; Refolo MG; Lippolis C; Carella N; Messa C; Cavallini A; Carr BI
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1237-1245. PubMed ID: 25907508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 mediates regorafenib-induced apoptosis in hepatocellular carcinoma.
    Tai WT; Chu PY; Shiau CW; Chen YL; Li YS; Hung MH; Chen LJ; Chen PL; Su JC; Lin PY; Yu HC; Chen KF
    Clin Cancer Res; 2014 Nov; 20(22):5768-76. PubMed ID: 25248379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: growth inhibition, quiescence, and recovery.
    Carr BI; Cavallini A; Lippolis C; D'Alessandro R; Messa C; Refolo MG; Tafaro A
    J Cell Physiol; 2013 Feb; 228(2):292-7. PubMed ID: 22777740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells.
    Refolo MG; Lippolis C; Carella N; Cavallini A; Messa C; D'Alessandro R
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.
    Yang J; Pi C; Wang G
    Biomed Pharmacother; 2018 Jul; 103():699-707. PubMed ID: 29680738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1.
    Lippolis C; Refolo MG; D'Alessandro R; Carella N; Messa C; Cavallini A; Carr BI
    J Exp Clin Cancer Res; 2015 Sep; 34(1):90. PubMed ID: 26329608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells.
    Tsai JJ; Pan PJ; Hsu FT
    Oncol Rep; 2017 Feb; 37(2):1036-1044. PubMed ID: 28000898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regorafenib and ginsenoside combination therapy: inhibition of HepG2 cell growth through modulating survivin and caspase-3 gene expression.
    Wang B; Wang F; Ding A; Zhao H; Bu X
    Clin Transl Oncol; 2020 Sep; 22(9):1491-1498. PubMed ID: 31965535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib.
    Fondevila F; Méndez-Blanco C; Fernández-Palanca P; Payo-Serafín T; van Pelt J; Verslype C; González-Gallego J; Mauriz JL
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with metformin and IL-12 to inhibit the growth of hepatic carcinoma by promoting apoptosis and autophagy in HepG2-bearing mice.
    Jin Z; Jia BX; Tan LD; Chen QM; Liu YH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12368-12379. PubMed ID: 33336757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines.
    Takuma K; Fujihara S; Fujita K; Iwama H; Nakahara M; Oura K; Tadokoro T; Mimura S; Tani J; Shi T; Morishita A; Kobara H; Himoto T; Masaki T
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines.
    Sasaki R; Kanda T; Fujisawa M; Matsumoto N; Masuzaki R; Ogawa M; Matsuoka S; Kuroda K; Moriyama M
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Regorafenib on P2X7 Receptor Expression and Different Oncogenic Signaling Pathways in a Human Breast Cancer Cell Line: A Potential of New Insight of the Antitumor Effects of Regorafenib.
    Salahuddin MM; Omran GA; Helmy MW; Houssen ME
    Curr Issues Mol Biol; 2021 Dec; 43(3):2199-2209. PubMed ID: 34940128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibility of regorafenib effects in hepatocellular carcinoma cells.
    D'Alessandro R; Refolo MG; Lippolis C; Messa C; Cavallini A; Rossi R; Resta L; Di Carlo A; Carr BI
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):869-77. PubMed ID: 23959464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procyanidins, from Castanea mollissima Bl. shell, induces autophagy following apoptosis associated with PI3K/AKT/mTOR inhibition in HepG2 cells.
    Zhang H; Luo X; Ke J; Duan Y; He Y; Zhang D; Cai M; Sun G; Sun X
    Biomed Pharmacother; 2016 Jul; 81():15-24. PubMed ID: 27261572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
    Kim HY; Jung HU; Yoo SH; Yoo KS; Cheong J; Park BS; Yun I; Yoo YH
    Cancer Lett; 2014 Dec; 355(1):61-9. PubMed ID: 25218348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cFLIP overcomes acquired resistance to sorafenib via reducing ER stress‑related autophagy in hepatocellular carcinoma.
    Liu D; Fan Y; Li J; Cheng B; Lin W; Li X; Du J; Ling C
    Oncol Rep; 2018 Oct; 40(4):2206-2214. PubMed ID: 30066934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirt3 promotes hepatocellular carcinoma cells sensitivity to regorafenib through the acceleration of mitochondrial dysfunction.
    Wang R; Liu Y; Mi X; Chen Q; Jiang P; Hou J; Lin Y; Li S; Ji B; Fang Y
    Arch Biochem Biophys; 2020 Aug; 689():108415. PubMed ID: 32562663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.